• A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
• A mutational signature and ARID1A mutation associated with outcome in hepatocellular carcinoma
• A simple model to predict early recurrence of hepatocellular carcinoma after liver resection
• A special case of intrahepatic cholangiocarcinoma misdiagnosed as hepatic cystic echinococcosis
• Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study
• Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques
• Advancements in second-line treatment research for hepatocellular carcinoma
• Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care
• Assessment of the postoperative prognosis in patients with hepatocellular carcinoma using transient elastography: A systemic review and meta-analysis
• Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review
• Author Correction: Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design
• beta,beta-Dimethylacrylalkannin, a key component of Zicao, induces cell cycle arrest and necrosis in hepatocellular carcinoma cells
• Blood MALT1 serves as a potential biomarker reflecting the response and survival of immune-checkpoint-inhibitor therapy in advanced hepatocellular carcinoma
• Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma
• Causal Effects of Smoking, Alcohol Consumption, and Coffee Intake on Hepatobiliary and Pancreatic Diseases: A Mendelian Randomization Study
• CBX7 promotes choroidal neovascularization by activating the HIF-1α/VEGF pathway in choroidal vascular endothelial cells
• Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis
• Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma
• Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
• Cone Beam Computed Tomography for the Interventional Oncologist: A Practical Approach
• Correlations of LncRNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism
• Cross-continental insights into liver cancer: an East <em>vs.</em> West epidemiology
• Development and validation of a CT-based nomogram for accurate hepatocellular carcinoma detection in high risk patients
• Development and validation of a prognostic nomogram to predict the recurrence of AFP-negative and DCP-positive hepatocellular carcinoma after curative resection
• Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX
• Discovering the lipid metabolism-related hub genes of HCC-treated samples with PPARα agonist through weighted correlation network analysis
• Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis
• Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange and non-directed donor graft allocation
• GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma
• Genetic variants of m(6)A modification genes are associated with survival of HBV-related hepatocellular carcinoma
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing
• Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: A multicenter cohort study
• Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation
• Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection
• Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress
• Hepatoprotective effects of diosmin: a narrative review
• Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
• Imaging in Interventional Radiology: Applications of Contrast-Enhanced Ultrasound
• Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma
• Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma
• Impacts of smoking on alcoholic liver disease: a nationwide cohort study
• In-vivo and in-vitro toxicity evaluation of 2,3-dimethylquinoxaline: An antimicrobial found in a traditional herbal medicine
• Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study
• Inverse association between lung function and nonalcoholic fatty liver disease: An observational and mendelian randomization study
• Is mailed outreach and patient navigation a perfect solution to improve HCC screening?
• Lecithin-cholesterol acyltransferase is a potential tumor suppressor and predictive marker for hepatocellular carcinoma metastasis
• LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI
• Liver microbiome: an intrahepatic resident playing a role in liver diseases
• Liver transplantation for pediatric liver malignancies
• Living donor liver transplantation can be a rescue treatment for hepatocellular carcinoma
• Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer
• Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma
• Mixed hepatocellular carcinoma and high-grade neuroendocrine neoplasm with ambiguous histopathological features: a case report
• Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma
• NFKBIE is a predictive factor of survival and is correlated with immune infiltration and antigen processing and presentation in hepatocellular carcinoma
• NLR stability predicts response to immune checkpoint inhibitors in advanced hepatocellular carcinoma
• NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease
• Novel immunotherapeutics against LGR5 to target multiple cancer types
• NXPH4 mediated by m⁵C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation
• Pan-cancer analysis reveals <em>GGPS1</em> plays an important role in tumorigenesis in multiple tumor types
• Parenchymal sparing anatomical liver resections for hepatocellular carcinoma
• Porous Organic Polymer-Based Nanocomposites for Hypoxia Relieving and Enhanced Chemotherapy in Hepatocellular Carcinoma
• Potential value and advances in research on bone mineral density (BMD) measurement in the auxiliary clinical assessment of hepatocellular carcinoma
• Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by downregulating periostin expression
• Preoperative Ultrasound Radomics to Predict Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma
• Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists
• Prevalence, management and outcomes of pulmonary metastases in hepatocellular carcinoma: a systematic review and meta-analysis
• Primary treatments for solitary hepatocellular carcinoma 3 cm: A systematic review and network meta-analysis
• Prognosis of operated hepatocellular carcinoma developed on non-cirrhotic liver
• Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy
• Quercetin inhibits endothelial & hepatocellular carcinoma cell crosstalk via reducing extracellular vesicle-mediated VEGFR2 mRNA transfer
• Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
• Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres
• Reappraisal of tacrolimus levels post liver transplant for hepatocellular carcinoma: A multicenter study toward personalized immunosuppression regimen
• Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
• Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment
• Risk of early hepatocellular carcinoma recurrence following liver resection: arbitrary specification or possible target to improve outcome?
• Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases
• Solitary Osseous Metastasis of Hepatocellular Carcinoma on SPECT/CT
• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8⁺ T cell exhaustion and anti-PD-1 resistance
• STOP-HCV-HCC Program: Privacy-Preserving Innovation for Remote Data Access Analytics at Federally Qualified Health Centers in South Texas
• Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
• Successful radical surgery for lymph node metastasis in a patient with hepatocellular carcinoma following atezolizumab plus bevacizumab combination therapy: a case report and literature review
• Suppressive effect of isofraxidin on the overexpression of IL-6 and its molecular mechanism in a TPA-treated human hepatocellular carcinoma cell line, HuH-7
• Talin1 promotes HCC progression by regulating NRG1/PI3K/AKT pathway
• Targeting PDHK1 by DCA to restore NK cell function in hepatocellular carcinoma
• The anti-tumor effects of cosmosiin through regulating AhR/CYP1A1-PPARγ in breast cancer
• The cellular senescence score (CSS) is a comprehensive biomarker to predict prognosis and assess senescence and immune characteristics in hepatocellular carcinoma (HCC)
• The current status and future of targeted-immune combination for hepatocellular carcinoma
• The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study
• The nuclear export protein XPO1 provides a peptide ligand for natural killer cells
• The potential of lenvatinib in breast cancer therapy
• Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
• Trapped in Endosome PEGylated Ultra-Small Iron Oxide Nanoparticles Enable Extraordinarily High MR Imaging Contrast for Hepatocellular Carcinomas
• Treatment of Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Systemic Therapy
• Ultrathin Gd-Oxide Nanosheet as Ultrasensitive Companion Diagnostic Tool for MR Imaging and Therapy of Submillimeter Microhepatocellular Carcinoma
• Unraveling the relationship between anoikis-related genes and cancer-associated fibroblasts in liver hepatocellular carcinoma
• Unveiling Endogenous Serum Peptides as Potential Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis
• Value of hepatic artery digital subtraction angiography in the detection of small hepatocellular carcinoma lesions
• ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells